Email This Article

Headlines & Perspectives
Biotech Mailbag: Lessons From Clinical Trials
By Adam Feuerstein
10/24/08 - 04:10 PM EDT
Senior Columnist Adam Feuerstein's column on Cell Genesys elicited some compliments -- and some negative mail from Dendreon fans.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,482.31 1,114.68 2,209.45 35.02
Oil *
79.13
UP
116.16
UP
14.76
UP
36.31
UP
1.22
10 Yr
3.50%
SPDR Gold
116.44
+1.12%
+1.34%
+1.67%
+3.61%
Data delayed 20 minutes

Brokerage Partners